KR101625891B1 - Composition for inhibiting quorum sensing or anti-bacterial composition comprising Nymphaea tetragona georgi extract - Google Patents
Composition for inhibiting quorum sensing or anti-bacterial composition comprising Nymphaea tetragona georgi extract Download PDFInfo
- Publication number
- KR101625891B1 KR101625891B1 KR1020130122095A KR20130122095A KR101625891B1 KR 101625891 B1 KR101625891 B1 KR 101625891B1 KR 1020130122095 A KR1020130122095 A KR 1020130122095A KR 20130122095 A KR20130122095 A KR 20130122095A KR 101625891 B1 KR101625891 B1 KR 101625891B1
- Authority
- KR
- South Korea
- Prior art keywords
- water
- water extract
- composition
- extract
- quorum
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 121
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 230000000844 anti-bacterial effect Effects 0.000 title claims description 3
- 230000002401 inhibitory effect Effects 0.000 title abstract description 26
- 230000018612 quorum sensing Effects 0.000 title abstract description 10
- 241000587753 Nymphaea tetragona Species 0.000 title description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 114
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 16
- 239000004480 active ingredient Substances 0.000 claims abstract description 10
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 241000209490 Nymphaea Species 0.000 claims description 13
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 10
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims description 7
- 240000000533 Capsicum pubescens Species 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000003674 animal food additive Substances 0.000 claims description 3
- 244000186654 Fockea angustifolia Species 0.000 claims 1
- 235000015210 Fockea angustifolia Nutrition 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 abstract description 13
- 244000005700 microbiome Species 0.000 abstract description 9
- 230000015572 biosynthetic process Effects 0.000 abstract description 6
- 238000004891 communication Methods 0.000 abstract description 5
- 230000003115 biocidal effect Effects 0.000 abstract description 4
- 231100000956 nontoxicity Toxicity 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 15
- 239000002609 medium Substances 0.000 description 15
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 241000588881 Chromobacterium Species 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- 230000002195 synergetic effect Effects 0.000 description 8
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 7
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 7
- 241000607142 Salmonella Species 0.000 description 7
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- YNCMLFHHXWETLD-UHFFFAOYSA-N pyocyanin Chemical compound CN1C2=CC=CC=C2N=C2C1=CC=CC2=O YNCMLFHHXWETLD-UHFFFAOYSA-N 0.000 description 7
- 229960001285 quercetin Drugs 0.000 description 7
- 235000005875 quercetin Nutrition 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000006142 Luria-Bertani Agar Substances 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 3
- 229930182566 Gentamicin Natural products 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 229960004821 amikacin Drugs 0.000 description 3
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 3
- 229960003022 amoxicillin Drugs 0.000 description 3
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 3
- 230000008447 perception Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 229960004441 tyrosine Drugs 0.000 description 3
- XAPNKXIRQFHCHN-QGOAFFKASA-N violacein Chemical compound O=C\1NC2=CC=CC=C2C/1=C(C(=O)N1)/C=C1C1=CNC2=CC=C(O)C=C21 XAPNKXIRQFHCHN-QGOAFFKASA-N 0.000 description 3
- LEJQUNAZZRYZKJ-UHFFFAOYSA-N violacein Natural products Oc1ccc2NCC(C3=CC(=C4/C(=O)Nc5ccccc45)C(=O)N3)c2c1 LEJQUNAZZRYZKJ-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 206010058874 Viraemia Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- -1 olive oil Chemical compound 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- ZWVBCRHOFNVAHM-UHFFFAOYSA-N 5-methyl-10h-phenazin-1-ol Chemical compound C1=CC=C2N(C)C3=CC=CC=C3NC2=C1O ZWVBCRHOFNVAHM-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 241000356187 Euphorbia aeruginosa Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- BPFYOAJNDMUVBL-UHFFFAOYSA-N LSM-5799 Chemical compound C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3N(C)COC1=C32 BPFYOAJNDMUVBL-UHFFFAOYSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010053210 Phycocyanin Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010039438 Salmonella Infections Diseases 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000004083 gastrointestinal agent Substances 0.000 description 1
- 229940127227 gastrointestinal drug Drugs 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940124452 immunizing agent Drugs 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960002531 marbofloxacin Drugs 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 206010039447 salmonellosis Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000002511 suppository base Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000010610 time kill assay Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/10—Preserving against microbes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
본 발명은 수련 추출물을 유효성분으로 포함하는 정족수 인식 억제용 조성물, 항균용 조성물 또는 사료 첨가용 조성물에 관한 것이다. 본 발명에 따른 수련 추출물은 독성이 없으며, 미생물 간의 의사소통을 방해하는 정족수 인식 억제 활성을 가지고 있어, 미생물의 번식과 생물막의 형성 등을 효과적으로 차단할 수 있고, 기존의 항균제와 병용하였을 때 우수한 항균 상승 작용을 가지고 있어, 정족수 인식 억제용 조성물, 항균용 조성물 또는 사료 첨가용 조성물로 유용하게 이용될 수 있다. The present invention relates to a composition for inhibiting the recognition of a quorum water, a composition for antibiosis or a composition for feed addition, which comprises a water extract as an active ingredient. The water extract according to the present invention has no toxicity and has a quorum sensing inhibitory activity which interferes with the communication between microorganisms, thereby effectively preventing the propagation of microorganisms and formation of a biofilm, and when used in combination with existing antimicrobial agents, And can be effectively used as a composition for inhibiting the recognition of a quorum, an antimicrobial composition or a composition for adding a feed.
Description
본 발명은 수련 추출물을 유효성분으로 포함하는 정족수 인식 억제용 조성물, 항균용 조성물 또는 사료 첨가용 조성물에 관한 것이다.
The present invention relates to a composition for inhibiting the recognition of a quorum water, a composition for antibiosis or a composition for feed addition, which comprises a water extract as an active ingredient.
세균은 일정 수준의 세포농도에 도달하면, 자신이 생산하는 화학적 언어를 이용하여 세포들 서로 간에 신호를 전달하고, 이를 통해 특정 유전자의 발현을 조절한다. 이렇게 유전자의 발현이 개체 밀도에 의존하는 기작을 정족수 인식 (quorum sensing; QS)이라 한다. 정족수 인식 기작은 각각의 세균 개체들이 자기유도 물질(autoinducer)이나 페로몬(pheromone)과 같은 저분자의 신호전달 물질들을 세포 외부에 축적하여 활발한 증식을 유도하고 일정 정족수(quorum)를 채워 유전자 발현을 유도하는 일련의 생물 현상을 지칭하는 것으로, 세균들은 상기 정족수 인식 기작을 통하여 생물막(biofilm)의 형성, 발병력(virulence), 생체발광(bioluminescence), 항생제 생산 또는 접합에 의한 종양유도 플라스미드(Ti plasmid)의 전달 등과 같은 다양한 생리현상을 조절한다. When bacteria reach a certain level of cell density, they use the chemical language they produce to transmit signals to and from each other, thereby regulating the expression of specific genes. The mechanism by which gene expression depends on the density of individuals is called quorum sensing (QS). The quorum sensing mechanism is a mechanism in which each bacterial individual accumulates low-molecular signaling substances such as autoinducer or pheromone into the cell to induce active proliferation and to induce gene expression by filling a certain quorum Refers to a series of biological phenomena. Bacteria are formed by the formation of biofilm, virulence, bioluminescence, antibiotic production or conjugation of tumor-derived plasmids (Ti plasmid) through the quorum sensing mechanism And the like.
세균들이 의사소통을 통하여 이루는 대표적인 기능이 생물막(biofilm)이다. 생물막은 미생물의 대사과정에서 분비되는 세포외 고분자 물질과 부착된 미생물에 의해 형성된 표면상의 부드러운 점액층을 말한다. 미생물이 다양한 무생물 및 생물체의 표면에 부착하여 생물막을 형성하고 개체군/군집을 이루는 경우, 영양분의 고갈, 산성도의 변화, 삼투압의 증감, 온도의 변화, 산화적 충격, 독성물질의 노출 등 여러 환경적인 스트레스에 대한 저항성이 현저히 증가된다고 알려져 있다. 또한, 사람의 장기에 머물면서 수많은 병증을 유발한다. 따라서 상기와 같은 생물막(biofilm)의 형성을 억제하는 항균제 개발이 요구되고 있다.Biofilm is a typical function of bacteria through communication. Biofilm refers to a smooth mucous layer on the surface formed by extracellular polymeric materials and attached microorganisms secreted during the metabolism of microorganisms. When microorganisms attach to various inanimate objects and organisms' surfaces to form a biofilm and form populations / communities, there are various environmental conditions such as depletion of nutrients, changes in acidity, changes in osmotic pressure, changes in temperature, oxidative shock, It is known that the resistance to stress is significantly increased. It also causes many ailments while staying in human organs. Therefore, development of an antibacterial agent for inhibiting the formation of biofilm as described above is required.
한편, 수련(Nymphaea tetragona georgi)은 미나리아재비목 수련과 수련속 식물로, 우리나라에서는 관상용으로 전국에서 재배를 한다. 종자와 뿌리 줄기는 녹말을 많이 함유하고 있으며 누파리딘이라는 알칼로이드를 함유하고 있어 위장약으로 사용되고 있다. 또한 수련 추출물은 항스트레스 또는 항우울증에 대한 효과가 뛰어나 식품, 식품첨가제 또는 약제로 사용 가능한 것으로 알려져 있으며 (등록특허 10-0876440), 항산화 활성이 있다고 알려져 두피에 대한 정화 및 진정효과가 우수한 화장료 조성물로 사용할 수 있다고 알려져 있다(공개특허 10-2011-0085371, 10-2012-0057197). On the other hand, the water lily (Nymphaea tetragona georgi) is a plant belonging to the family Ranunculaceae and it is cultivated in the whole country for ornamental use in our country. Seeds and rootstocks contain a lot of starch and contain alkaloids called nupalidins and are used as gastrointestinal drugs. In addition, the water extract has excellent anti-stress or antidepressant effect and is known to be used as food, food additive or medicine (Patent No. 10-0876440). It is known that it has antioxidative activity, and cosmetic composition (Patent Publication No. 10-2011-0085371, 10-2012-0057197).
상기한 바와 같이, 수련 추출물의 다양한 약리효과가 알려져 있으나, 수련 추출물이 정족수 인식 억제 활성을 가지고 있다는 것에 대해서는 전혀 알려져 있지 않으며, 이에 대한 연구도 전무한 상태이다. As described above, various pharmacological effects of the water extract are known, but it is not known at all that the water extract has a quorum sensing inhibitory activity, and there is no research on this.
이에, 본 발명자는 세균을 죽이는 것 뿐 아니라 세균들의 의사 소통을 방해하여 세균들의 번식을 미연에 방지할 수 있는 정족수 억제 활성을 가진 새로운 물질을 찾기 위해 노력한 결과, 수련 추출물이 우수한 정족수 인식 억제 활성이 있음을 확인함으로써, 본 발명을 완성하였다.
Accordingly, the present inventors have sought to find a new substance having a quorum-suppressing activity that can prevent the propagation of bacteria by interfering with the communication of germs as well as killing the bacteria. As a result, the water extract has a superior quercetin recognition inhibitory activity The present invention has been completed.
본 발명의 목적은 수련 추출물을 유효성분으로 포함하는 정족수 인식 억제용 조성물, 항균용 조성물 또는 사료 첨가용 조성물을 제공하는 것이다.
It is an object of the present invention to provide a composition for inhibiting the recognition of a quorum water, a composition for antimicrobial use or a composition for feed addition comprising a water extract as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 수련 추출물을 유효성분으로 포함하는 정족수 인식 억제용 조성물, 항균용 조성물 또는 사료 첨가용 조성물을 제공한다.
In order to achieve the above object, the present invention provides a composition for suppressing the recognition of a quorum water, a composition for antibiosis or a composition for adding a feed comprising an extract of a water lily as an active ingredient.
본 발명에 따른 수련 추출물은 독성이 없으며, 미생물 간의 의사소통을 방해하는 정족수 인식 억제 활성을 가지고 있어, 미생물의 번식과 생물막의 형성 등을 효과적으로 차단할 수 있고, 기존의 항균제와 병용하였을 때 우수한 항균 상승 작용을 가지고 있어, 정족수 인식 억제용 조성물, 항균용 조성물 또는 사료 첨가용 조성물로 유용하게 이용될 수 있다.
The water extract according to the present invention has no toxicity and has a quorum sensing inhibitory activity which interferes with the communication between microorganisms, thereby effectively preventing the propagation of microorganisms and formation of a biofilm, and when used in combination with existing antimicrobial agents, And can be effectively used as a composition for inhibiting the recognition of a quorum, an antimicrobial composition or a composition for adding a feed.
도 1은 본 발명에 따른 수련 추출물의 수득 과정을 나타낸 모식도이다.
도 2는 수련 추출물의 크로모박테리움 바이레큠에 대한 정족수 인식 억제 활성을 나타낸 도이다 (A: 수련 추출물 2.5 mg/ml, B: 수련 추출물 1.25 mg/ml, C: 수련 추출물 0.625 mg/ml, D: 수련 추출물 0.3125 mg/ml, F: 퓨라논 10 μg/disc, M: 메탄올).
도 3은 수련 추출물의 슈도모나스 애루지노사에 대한 정족수 인식 억제 활성을 나타낸 도이다 (A: 수련 추출물 5 mg/ml, B: 수련 추출물 2.5 mg/ml, C: 수련 추출물 1.25 mg/ml, D: 수련 추출물 0.625 mg/ml, E: 수련 추출물 0.3125 mg/ml, F: 수련 추출물 미첨가).
도 4는 수련 추출물이 슈도모나스 애루지노사의 생물막 형성에 미치는 영향을 나타낸 도이다 (A: 수련 추출물 미첨가, B: 수련 추출물 5 mg/ml, C: 수련 추출물 10 mg/ml, D: 수련 추출물 20 mg/ml).
도 5는 수련 추출물의 슈도모나스 애루지노사에 대한 항균 활성을 나타낸 도이다.
도 6은 수련 추출물 및 기존 항균제(아미카신, 타이로신, 테트라사이클린, 아목시실린, 마보플록사신 또는 겐타마이신)의 병용 시 크로모박테리움 바이레큠에 대한 항균 활성을 나타낸 도이다.
도 7은 수련 추출물을 포함하는 사료 조성물의 살모넬라 증식 억제 효과를 나타낸 도이다. 1 is a schematic view showing the process of obtaining a water extract according to the present invention.
FIG. 2 is a graph showing the quercetin recognition inhibitory activity of the water extract of Chromobacterium bisreflex (A: water extract extract 2.5 mg / ml, B: water extract 1.25 mg / ml, C: water extract 0.625 mg / D: water extract extract 0.3125 mg / ml, F:
FIG. 3 is a graph showing the quercetin perception inhibitory activity of Pseudomonas aeruginosa extract of water extract (A:
FIG. 4 shows the effect of water extract on the biofilm formation of Pseudomonas aeruginosa (A: no water extract, B:
Fig. 5 is a graph showing antimicrobial activity against Pseudomonas aeruginosa of a water extract.
FIG. 6 is a graph showing antimicrobial activity against Chromobacterium bilecy when water extracts and conventional antimicrobial agents (amikacin, tyrosine, tetracycline, amoxicillin, magobactycoxin or gentamicin) are used in combination.
FIG. 7 is a graph showing the salmonellosis inhibitory effect of the feed composition containing the water extract. FIG.
이하, 본 발명에 대하여 보다 상세히 설명한다. Hereinafter, the present invention will be described in more detail.
본 발명은 수련 추출물을 유효성분으로 포함하는 정족수 인식 억제용 조성물, 항균용 조성물 또는 사료 첨가용 조성물을 제공한다.The present invention provides a composition for suppressing the recognition of a quorum water, a composition for antimicrobial use or a composition for feed addition, which comprises a water extract as an active ingredient.
본 발명의 조성물에서 유효성분인 수련 추출물은 하기와 같은 방법으로 수득될 수 있다. The water extract which is an active ingredient in the composition of the present invention can be obtained by the following method.
먼저, 수련을 물로 세척하여 이물질을 제거한 후, 세단 및 건조한다. 수련은 재배한 것 또는 시판되는 것 등을 제한 없이 사용할 수 있다. 건조된 수련을 분말화 한 후, 적당한 양의 용매를 가하여 완전히 침지되도록 한다. 추출 방법은 실온에서 함침하거나 가온할 수 있다. 상기 추출 용매는 이에 제한되지 않으나, 물, 탄소수 1 내지 4의 알코올 및 이들의 혼합 용매로부터 선택된 1종 이상의 용매를 이용할 수 있다. 본 발명의 일 실시예에서는 건조된 수련 분말을 분말 1: 에테르 5~15의 중량 비율로 진탕 후 정치하여 상층액인 에테르 층을 제거하고, 남아있는 하층의 에테르를 진공 건조기로 모두 증발시킨 후, 건조된 수련 분말을 100% 에탄올, 40~60% 에탄올 및 열수로 차례로 추출한 후, 독립적으로 수득한 각각의 추출물을 1~2:1~2:1~2의 중량 비율로 혼합한다. 상기 추출물을 농축 및 동결 건조한 후, 유기 용매에 용해시켜 상층액을 필터한 후 정제하여 최종 수련 추출물을 수득한다. First, the water lily is washed with water to remove impurities, sedimented and dried. The water lily can be cultivated or marketed without limitation. After the dried water lily is pulverized, an appropriate amount of solvent is added so that it is completely immersed. The extraction method can be impregnated or warmed at room temperature. The extraction solvent is not limited thereto, and at least one solvent selected from water, alcohols having 1 to 4 carbon atoms, and a mixed solvent thereof may be used. In one embodiment of the present invention, the dried water lily powder is shaken at a weight ratio of powder 1:
본 발명에 따른 수련 추출물은 독성이 없으며, 미생물 간의 의사소통을 방해하는 정족수 인식 억제 활성을 가지고 있어, 미생물의 번식과 생물막 (biofilm)의 형성 등을 효과적으로 차단할 수 있으며, 기존의 항균제와 병용하였을 때 우수한 항균 상승 작용을 가지고 있다. The water extract according to the present invention has no toxicity and has a quorum sensing inhibiting activity which interferes with the communication between microorganisms and can effectively block the propagation of microorganisms and the formation of biofilm. When used in combination with existing antimicrobial agents It has an excellent antimicrobial synergistic effect.
따라서, 본 발명에 따른 수련 추출물은 세균의 감염을 차단하거나 생물막의 형성을 방지할 필요가 있는 각종 생활 도구 및 의료 기구 등에 다양하게 이용될 수 있으며, 향균제 및 균주에 의해 발생하는 질병의 치료제, 사료 첨가용 조성물 등으로 유용하게 이용될 수 있다.
Therefore, the water extract according to the present invention can be widely used for a variety of life tools and medical instruments that need to prevent the infection of bacteria or prevent the formation of biofilm, and can be used as a therapeutic agent for diseases caused by antibacterial agents and strains, A composition for addition, and the like.
본 발명의 조성물이 정족수 인식 억제 활성 또는 항균 활성을 나타내는 균주에는 그람 음성 세균 및 그람 양성 세균이 포함되며, 예를 들어, 크로모박테리움 바일레큠 (C. violaceum), 슈도모나스 애루지노사 (P. aeruginosa), 대장균 (E. coli), 파스튜렐라 헤몰리티카 (P. hemolytica), 황색 포도상구균 (S. aureus), 살모넬라 콜라라수이스 (S. cholerasuis), 살모넬라 티피뮤리움 (S. typhimurium) 등을 포함하나 이에 제한되지 않는다. Examples of the strain exhibiting a quorum-sensing inhibitory activity or antimicrobial activity include gram-negative bacteria and gram-positive bacteria. Examples of the bacteria include C. violaceum, Pseudomonas aeruginosa, Pseudomonas aeruginosa, E. aeruginosa, E. coli, P. hemolytica, S. aureus, S. cholerasuis, S. typhimurium, S. typhimurium, ), And the like.
본 발명의 조성물은 통상적으로 사용하는 적절한 담체, 부형제 또는 희석제를 더 포함할 수 있다. 본 발명의 조성물에 포함될 수 있는 담체, 부형제 또는 희석제로는, 락토오스, 덱스트로오스, 수크로오스, 소르비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로오스, 메틸 셀룰로오스, 미정질 셀룰로오스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유등이 있으며, 이에 제한되지 않는다. The compositions of the present invention may further comprise suitable carriers, excipients or diluents conventionally used. Examples of the carrier, excipient or diluent which can be contained in the composition of the present invention include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, cellulose , Methylcellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, and mineral oil.
본 발명의 조성물은 보조 성분으로 안식향산나트륨(Sodium benzonate), 알란토인(allantoin : 5-우레이드히단토인), 프로피온산나트륨(Sodium Propionate), 시트랄, 베타글루칸 등을 포함하는 보존제, 항균제, 항진균제, 면역증강제 등을 더 포함할 수 있으며 이에 제한되지 않는다. The composition of the present invention can be used as a preservative, antimicrobial agent, antifungal agent, immunizing agent including sodium benzonate, allantoin, sodium propionate, citral, betaglucan, Enhancing agents, and the like.
본 발명의 조성물은 통상의 방법에 따라 경구 또는 비경구의 제형으로 투여될 수 있으며, 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 조성물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트 (calcium carbonate), 수크로오스, 락토오스, 젤라틴 등을 섞어 조제된다. 또한 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용된다. 경구투여를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순 희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구 투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제가 포함된다. 또한, 비수성용제, 현탁제로는 프로필렌글리콜 (propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔 (witepsol), 마크로골, 트윈 (tween) 61, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다.The composition of the present invention may be administered orally or parenterally in a conventional manner. In the case of formulation, a diluent or excipient such as a filler, an extender, a binder, a wetting agent, a disintegrant, do. Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain at least one excipient such as starch, calcium carbonate, sucrose, lactose, Gelatin and the like. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used. Liquid preparations for oral administration include suspensions, solutions, emulsions, syrups and the like. Various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like may be included in addition to water and liquid paraffin, which are simple diluents commonly used. have. Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Examples of the non-aqueous solvent and suspension include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like. Examples of the suppository base include witepsol, macrogol, tween 61, cacao butter, laurin, glycerogelatin and the like.
본 발명에 따른 유효성분의 제제 내 함유량은 체내에서의 활성 성분의 흡수도, 불활성화율, 배설속도, 연령 및 상태 등에 따라 적절히 선택할 수 있으며, 이에 제한되지 않는다. 예를 들어, 본 발명의 조성물을 사료로 만들어 제제화할 시, 수련 추출물의 함유량은 사료 총 중량에 대하여 0.1% 내지 20%, 바람직하게는 0.1% 내지 10%(중량%)로 첨가될 수 있으며, 이에 제한되지 않는다.
The content of the active ingredient according to the present invention in the preparation can be appropriately selected depending on the degree of absorption, inactivation rate, excretion rate, age and condition of the active ingredient in the body, and is not limited thereto. For example, when the composition of the present invention is formulated into a feed, the content of the water extract may be added in an amount of 0.1% to 20%, preferably 0.1% to 10% (weight%) based on the total weight of the feed, But is not limited thereto.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나 하기의 실시예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 실시예에 의해 본 발명의 내용이 한정되는 것은 아니다.
Hereinafter, preferred embodiments of the present invention will be described in order to facilitate understanding of the present invention. However, the following examples are provided only for the purpose of easier understanding of the present invention, and the present invention is not limited by the examples.
실시예 1. 수련 추출물의 제조Example 1. Preparation of water extract
경상북도 경주 연꽃에서 채취한 수련(Nymphaea tetragona GEORGI)을 이용하였다. 먼저, 수련 뿌리를 깨끗하게 세척 후 1 cm정도의 크기로 세단 후 건조하였다 (수분 10% 미만). 상기 건조된 수련 뿌리를 분말화 한 후, 분말 1: 에테르 10의 중량 비율로 진탕 후 정치하여 상층액인 에테르 층을 제거하였다. 남아있는 하층의 에테르를 진공 건조기로 모두 증발시킨 후, 건조된 수련 분말을 100%(v/v) 에탄올 (에탄올:수련 분말 = 20:1의 중량 비율), 50% 에탄올 및 열수로 차례로 추출하였다. 상기 과정을 통해 독립적으로 수득한 각각의 추출물을 1:1:1의 중량 비율로 혼합한 후, 농축 및 동결 건조 하여 분말 상태의 수련 추출물을 얻었다. 상기 분말 상태의 수련 추출물을 메탄올에 용해시킨 후 상층액을 필터하고, RP-Sepak 컬럼으로 정제하여 최종 수련 추출물을 수득하였다. The water lily (Nymphaea tetragona GEORGI) collected from the Gyeongju lotus in Gyeongbuk province was used. First, the water lily roots were washed cleanly, then dried in a size of about 1 cm and dried (less than 10% moisture). The dried water lily roots were pulverized, and then the powder was shaken at a weight ratio of 1:
이상의 제조과정을 도 1에 모식도로 나타내었다.
The above-mentioned manufacturing process is shown in FIG. 1 as a schematic diagram.
실험예 1. 수련 추출물의 정족수 인식 억제 활성 검증EXPERIMENTAL EXAMPLE 1. Verification of quorum-recognition inhibitory activity of water extracts
상기 실시예 1에서 수득한 수련 추출물의 정족수 인식 억제 활성을 검증하기 위하여, 자기 유도 물질에 의해 정족수 인식 작용을 한다고 알려진 크로모박테리움 바이레큠(C. violaceum (ATCC12472)) 및 슈도모나스 애루지노사(Pseudomonas aeurginosa (PAO1))를 이용하여 정족수 인식 억제 활성을 확인하였다. In order to examine the quan- tity recognition inhibitory activity of the water extract obtained in Example 1, it was confirmed that quercetin peroxidase (C. violaceum (ATCC12472)) and Pseudomonas aeruginosa Pseudomonas aeurginosa (PAO1)).
크로모박테리룸 바이레큠을 이용한 정족수 인식 억제 활성은 하기와 같은 실험을 통해 확인하였다. 먼저 LB(Luria-Britani) 아가 배지에 5x106 cfu/ml의 크로모박테리움 바이레큠을 접종한 후, 페트리 디쉬(90 x 15 mm)에 부어 LB 아가 플레이트를 만들었다. 다양한 농도(2.5-0.3125 mg/ml)의 수련 추출물을 멸균된 페이퍼 디스크(Ø= 8 mm)에 떨어뜨린 뒤 건조한 후, 이를 상기 LB 아가 플레이트에 올리고, 24시간동안 30°C에서 배양하였다. 그 후 각 농도의 색소억제환을 측정하였다(digital vernier calipers, Mitotoyo, Japan). 양성 대조군으로 퓨라논(Furanone), 음성 대조군으로 메탄올을 이용하였다. 그 결과를 도 2에 나타내었다. The quercetin recognition inhibition activity using the chromobacterium viremia was confirmed by the following experiment. First, LB (Luria-Britani) agar medium was inoculated with 5x10 6 cfu / ml of chromobacterium bimetallicum, and then poured into petri dishes (90 x 15 mm) to prepare LB agar plates. Water extracts of various concentrations (2.5-0.3125 mg / ml) were dropped on a sterilized paper disk (Ø = 8 mm), dried, and placed on the LB agar plate and cultured at 30 ° C for 24 hours. After that, pigment inhibition rings at various concentrations were measured (digital vernier calipers, Mitotoyo, Japan). Furanone was used as a positive control and methanol was used as a negative control. The results are shown in Fig.
도 2에 나타낸 바와 같이, 본 발명의 수련 추출물은 농도 의존적으로 크로모박테리움 바이레큠의 정족수 인식을 억제함을 확인하였다.
As shown in FIG. 2, it was confirmed that the water extract of the present invention inhibited the quorum recognition of chromobacterium-biasedis in a concentration-dependent manner.
또한, 슈도모나스 애루지노사를 이용한 정족수 인식 억제 활성은 하기와 같은 실험을 통해 확인하였다. 0.5% 글루코오스를 함유한 LB 아가 배지에 다양한 농도(2.5-0.3125 mg/ml)의 수련 추출물을 첨가한 후, 이를 플레이트로 만들었다. 상기 플레이트 중앙에 슈도모나스 애루지노사의 단일 콜로니를 접종한 후, 48시간 동안 37°C에서 배양하였다. 대조군으로 수련 추출물을 포함하지 않은 LB 아가 플레이트를 이용하였다. 그 결과를 도 3에 나타내었다.In addition, quercetin recognition inhibition activity using Pseudomonas aeruginosa was confirmed by the following experiment. Various concentrations (2.5-0.3125 mg / ml) of water extracts were added to the LB agar medium containing 0.5% glucose, which was then plated. A single colony of Pseudomonas aeruginosa was inoculated at the center of the plate and cultured at 37 ° C for 48 hours. As control, LB agar plates without water extract were used. The results are shown in Fig.
도 3에 나타낸 바와 같이, 본 발명의 수련 추출물은 슈도모나스 애루지노사의 이동을 억제하는 우수한 정족수 인식 억제 활성을 가지고 있음을 확인하였다.
As shown in Fig. 3, it was confirmed that the water extract of the present invention had a superior quorum recognition performance inhibiting the migration of Pseudomonas aeruginosa.
실험예 2. 수련 추출물이 크로모박테리움 바이레큠의 정족수 인식 억제에 미치는 영향 검증Experimental Example 2. Effect of Water Extract on the Inhibition of Quorum Identification of Chromobacterium bisrefil
상기 실험예 1에서 확인한 바와 같이, 수련 추출물이 크로모박테리움 바이레큠의 정족수 인식 억제에 미치는 영향을 재 검증하기 위하여, violacein 색소 억제 활성을 측정하였다. 먼저, 다양한 농도(2.5-0.625 mg/ml)의 수련 추출물을 포함하는 LB 배지에 5x106 cfu/ml의 크로모박테리움 바이레큠을 접종하고, 24시간 동안 30°C에서 진탕배양하였다. 양성 대조군으로 퓨라논(Furanone), 음성 대조군으로 메탄올을 포함하는 LB 배지를 이용하였다. 각 배지에서 Violacein 색소를 elsewhere(Choo et al. 2006)에 설명된 방법에 따라 추출 및 정량화하였다. 그 결과를 표 1에 나타내었다. As shown in Experimental Example 1, in order to reexamine the effect of the water extract on quorum recognition perception of chromobacterium viremia, violacein pigment inhibitory activity was measured. First, 5 × 10 6 cfu / ml of chromobacterium bimetallicum was inoculated into LB medium containing water extracts of various concentrations (2.5-0.625 mg / ml) and cultured for 24 hours at 30 ° C. with shaking. Furanone was used as a positive control, and LB medium containing methanol as a negative control was used. Violacein pigments were extracted and quantified in each medium according to the method described in elsewhere (Choo et al. 2006). The results are shown in Table 1.
표 1에 나타낸 바와 같이, 본 발명의 수련 추출물은 농도 의존적으로 violacein 색소의 생성을 억제하였으며, 이를 통해 수련 추출물이 크로모박테리움 바이레큠의 정족수 인식을 억제함을 확인하였다.
As shown in Table 1, the water extract of the present invention inhibited the production of violacein pigment in a concentration-dependent manner, and thus it was confirmed that the water extract extract inhibited the quorum recognition of chromobacterium-biasedis.
실험예 3. 수련 추출물이 슈도모나스 애루지노사의 정족수 인식 억제에 미치는 영향 검증Experimental Example 3: Effect of water extract on the inhibition of quorum recognition by Pseudomonas aeruginosa
상기 실험예 1에서 확인한 바와 같이, 수련 추출물이 슈도모나스 애루지노사의 정족수 인식 억제에 미치는 영향을 재 검증하기 위하여, 피오시아닌 (Pyocyanin) 생성 억제 활성 및 LasA단백질 분해 효소 활성을 측정하였다. 피오시아닌(Pyocyanin, 1-hydroxy-5-methyl-phenazine)은 슈도모나스 애루지노사가 생산하는 화합물 중의 하나로서, 특징적인 청록색을 띄는 산화-환원 활성물질이며, 정족수 인식의 조절을 받는 유전자들의 발현을 증가시키는 최종 신호 인자로 최근 제안되었다. As shown in Experimental Example 1, the activity of inhibiting Pyocyanin production and the activity of LasA protease were measured in order to reexamine the effect of the water extract on the quorum recognition perception of Pseudomonas aeruginosa. Pyocyanin (1-hydroxy-5-methyl-phenazine) is one of the compounds produced by Pseudomonas aeruginosa and is a characteristic blue-green oxidation-reduction active substance. It expresses genes regulated by quorum recognition As a final signaling factor.
먼저, 피오시아닌 생성 억제 활성을 측정하기 위하여, 5 ml의 다양한 농도(2.5-0.625 mg/ml)의 수련 추출물을 포함하는 LB 배지에서 자란 정체기의 슈도모나스 애루지노사에 3 ml의 클로로포름을 넣고 30초 간 볼텍싱하여 혼합하였다. 수성층은 버리고, 클로로포름층을 1 ml의 0.2N HCI와 섞었다. 상기 혼합물을 30초 간 볼텍싱하고 10분간 8000 x g로 원심분리하였다. 상층의 분홍색 층의 흡광도를 마이크로플레이트 리더기(Molecular device, Sunnyvale, CA, USA)를 이용하여 520 nm의 파장에서 측정하였다. 양성 대조군으로 퓨라논(Furanone), 음성 대조군으로 아무것도 포함하지 않은 LB 배지를 이용하였다. First, 3 ml of chloroform was added to Pseudomonas aeruginosa grown in an LB medium containing 5 ml of various concentrations (2.5-0.625 mg / ml) of water extracts to measure phycocyanin production inhibitory activity. Followed by vortexing for a few seconds. The aqueous layer was discarded and the chloroform layer was mixed with 1 ml of 0.2N HCI. The mixture was vortexed for 30 seconds and centrifuged at 8000 x g for 10 minutes. The absorbance of the upper layer of the pink layer was measured at a wavelength of 520 nm using a microplate reader (Molecular device, Sunnyvale, Calif., USA). Furanone was used as a positive control, and LB medium was used as a negative control.
또한, LasA 단백질 분해 효소 활성을 측정하기 위하여, 황색 포도상구균을 하룻밤 동안 LB 배지에서 배양한 후, 10 ml를 분리하여 이를 10 분 동안 끓이고, 10,000 × g에서 10 분간 원심 분리하였다. 펠렛을 0.02 M Tris 완충액(pH = 8.5)에 현탁하였다. 슈도모나스 애루지노사의 배양 상층액 100 ㎕에 황색 포도상구균 현탁액 900 ㎕를 첨가하고 마이크로플레이트 리더기를 이용하여 600 nm의 파장에서 흡광도를 1시간 간격으로 측정하였다. 양성 대조군으로 퓨라논(Furanone), 음성 대조군으로 아무것도 포함하지 않은 LB 배지를 이용하였다. 그 결과를 표 2에 나타내었다. In order to measure the activity of LasA protease, Staphylococcus aureus was cultured overnight in LB medium, and 10 ml of the strain was boiled for 10 minutes and centrifuged at 10,000 × g for 10 minutes. The pellet was suspended in 0.02 M Tris buffer (pH = 8.5). 900 μl of Staphylococcus aureus suspension was added to 100 μl of the culture supernatant of Pseudomonas aeruginosa and absorbance was measured at a wavelength of 600 nm at an interval of 1 hour using a microplate reader. Furanone was used as a positive control, and LB medium was used as a negative control. The results are shown in Table 2.
(μg/mL)Pyocyanin
(μg / mL)
표 2에 나타낸 바와 같이, 본 발명의 수련 추출물은 농도 의존적으로 슈도모나스 애루지노사의 피오시아닌 생성을 억제하고, 황색 포도상구균을 분해하는 LasA 활성을 억제하였으며, 이를 통해 수련 추출물이 슈도모나스 애루지노사의 정족수 인식을 억제함을 확인하였다.
As shown in Table 2, the water extract of the present invention inhibited the production of phyisianine of Pseudomonas aeruginosa in a concentration-dependent manner and inhibited the activity of LasA which decomposes Staphylococcus aureus. Thus, the water extract extract of Pseudomonas aeruginosa Of the quasi-
실험예 4. 수련 추출물이 생물막 생존에 미치는 영향 검증Experimental Example 4. Effect of Water Extract on Biofilm Survival
상기 실시예 1에서 수득한 수련 추출물의 정족수 인식 억제 활성을 검증하기 위하여, elsewhere (Karen and Iain 2008)의 방법을 약간 수정하여 생물막 생존 (Biofilm viability) 실험을 수행하였다. 보다 구체적으로, 50 ml 튜브에 7.5 ml의 0.5% 글루코오스가 포함된 LB 배지를 넣은 후, 여기에 멸균한 슬라이드를 넣어 슈도모나스 애루지노사의 생물막을 형성하게 한 후, 이를 1x PBS로 세척하였다. 상기 슬라이드를 다양한 농도(5-20 mg/ml)의 수련 추출물을 포함하는 LB 배지가 들어있는 새 50 ml 튜브로 옮긴 후, 24시간 동안 30°C에서 진탕배양하였다. 배양 후, 생물막을 BacLight live/dead stain으로 확인하였다. 그 결과를 도 4에 나타내었다. Biofilm viability experiments were carried out by modifying the method of elsewhere (Karen and Iain 2008) in order to verify the quercetin recognition inhibitory activity of the water extract obtained in Example 1 above. More specifically, 7.5 ml of LB medium containing 0.5% glucose was placed in a 50 ml tube, and sterilized slides were added thereto to form a biofilm of Pseudomonas aeruginosa, which was then washed with 1x PBS. The slides were transferred to fresh 50 ml tubes containing LB medium containing water extracts of various concentrations (5-20 mg / ml) and cultured at 30 ° C for 24 hours. After incubation, the biofilm was identified as BacLight live / dead stain. The results are shown in Fig.
도 4에 나타낸 바와 같이, 본 발명의 수련 추출물를 첨가한 경우 대조군에 비해 살아있는 세포를 의미하는 초록색 영역이 적게 나타남을 확인하였다.
As shown in FIG. 4, when the water extract of the present invention was added, it was confirmed that the green area, which means living cells, was smaller than the control group.
실험예 5. 수련 추출물의 항균 활성 검증Experimental Example 5. Antimicrobial Activity of Water Extract
5-1. MIC(minimal inhibitory concentration, 최소억제농도) 및 MBC(minimal bactericidal concentration, 최소살균농도)의 측정5-1. Measurement of MIC (minimal inhibitory concentration) and MBC (minimal bactericidal concentration)
상기 실시예 1에서 수득한 수련 추출물의 황색포도상구균, 슈도모나스 애루지노사 및 크로모박테리움 바이레큠에 대한 MIC 및 MBC를 임상 및 실험실 표준 협회의 가이드 라인(CLSI, 2007)에 따라 측정하였다. 보다 구체적으로, 세균 현탁액에 수련 추출물을 접종하고, 24 시간동안 배양하였을 때 눈에 띄는 성장이 없는 가장 낮은 농도를 MIC로 판단하였으며, MIC 이후 농도를 TSA에 도말하고 24 시간 동안 배양하였을 때, 99.9% 이하의 집락을 보이는 농도를 MBC로 판단하였다. 양성대조군으로 마보플록사신(Marbofloxacin)을 이용하였다. 그 결과를 표 3에 나타내었다. The MIC and MBC of S. aureus, Pseudomonas aeruginosa, and Chromobacterium bimetallicum obtained in Example 1 were measured according to the guidelines of Clinical and Laboratory Standards Association (CLSI, 2007). More specifically, when the extract was inoculated into the bacterial suspension and cultured for 24 hours, the lowest concentration without any noticeable growth was determined as MIC. When the concentration after MIC was applied to TSA and cultured for 24 hours, 99.9 % Of colonies were determined as MBC. Marbofloxacin was used as a positive control. The results are shown in Table 3.
표 3에 나타낸 바와 같이, 본 발명의 수련 추출물이 황색포도상구균, 슈도모나스 애루지노사 및 크로모박테리움 바이레큠에 대한 항균 활성을 가지고 있음을 확인하였다.
As shown in Table 3, it was confirmed that the water extract of the present invention had antimicrobial activity against Staphylococcus aureus, Pseudomonas aeruginosa and Chromobacterium bresenius.
5-2. Time-Kill assay5-2. Time-Kill assay
다양한 농도(20-0.624 mg/ml)의 수련 추출물을 포함한 MHB(Mueller Hinton Broth) 배지에 슈도모나스 애루지노사(5x105 cfu/ml)를 접종하고 24시간 동안 37°C에서 배양하였다. 1, 2, 4, 8, 12 및 24시간 뒤의 균수를 측정하기 위하여, 각 샘플로부터 0.1 ml씩을 취한 후 이를 10배 단계 희석하였다. 짝수(2, 4, 6, 8번째)의 희석 샘플을 20 μl씩 TSA 플레이트에 올리고 24시간 동안 37°C에서 배양하였다. 그 결과를 도 5에 나타내었다. Pseudomonas aeruginosa (5x10 5 cfu / ml) was inoculated into MHB (Mueller Hinton Broth) medium containing water extracts of various concentrations (20-0.624 mg / ml) and cultured at 37 ° C for 24 hours. To measure the number of bacteria at 1, 2, 4, 8, 12 and 24 hours later, 0.1 ml of each sample was taken and diluted 10-fold. Twenty microliters of even (2, 4, 6, 8 th) diluted samples were placed on TSA plates and incubated at 37 ° C for 24 h. The results are shown in Fig.
도 5에 나타낸 바와 같이, 본 발명의 수련 추출물은 5 mg/ml의 농도부터 슈도모나스 애루지노사의 성장을 억제하였으며, 20 mg/ml의 농도에서는 박테리아 활성을 억제함을 확인하였다.
As shown in FIG. 5, the water extract of the present invention inhibited the growth of Pseudomonas aeruginosa from a concentration of 5 mg / ml, and inhibited bacterial activity at a concentration of 20 mg / ml.
실험예 6. 수련 추출물 및 기존 항균제의 병용 시 항균 활성 검증Experimental Example 6. Antimicrobial activity test using water extract and conventional antimicrobial agent
6-1. 확산법6-1. Diffusion method
상기 실시예 1에서 수득한 수련 추출물과 기존 항균제의 병용 시 항균 활성을 검증하기 위하여, 크로모박테리움 바이레큠을 이용하여 확산법을 통한 항균 작용을 확인하였다. 각 종이 디스크에 각 시료(수련 추출물 및 기존 항균제(아미카신, 타이로신, 테트라사이클린, 아목시실린, 마보플록사신 또는 겐타마이신) 60 ㎕를 흡착시켜 시험 배지에 올린 후, 37 ℃에서 하룻밤 배양하여 저지환의 크기를 측정하였다. 그 결과를 도 6에 나타내었다. In order to verify the antimicrobial activity of the water extract obtained in Example 1 and the existing antimicrobial agent, antimicrobial activity was confirmed by the diffusion method using chromobacterium bimetallicus. 60 μl of each sample (water extract and existing antimicrobial agent (amikacin, tyrosine, tetracycline, amoxicillin, magofoxacin or gentamycin) was adsorbed on each paper disk and the test medium was incubated overnight at 37 ° C. The results are shown in Fig.
도 6에 나타낸 바와 같이, 본 발명의 수련 추출물은 기존 항균제(아미카신, 타이로신, 테트라사이클린, 아목시실린, 마보플록사신 또는 겐타마이신)와 상가 작용 또는 상승 작용이 있음을 확인하였다.
As shown in FIG. 6, the water extract of the present invention was found to have an adduct or synergistic action with existing antimicrobial agents (amikacin, tyrosine, tetracycline, amoxicillin, marbophloxacin or gentamicin).
6-2. 체커보드법6-2. Checkerboard method
상기 결과를 토대로, 수련 추출물과 마보플록사신의 병용 효과를 확인하기 위하여, 체커보드법 (checkerboard method)을 이용하여 하기와 같은 실험을 수행하였다. 대상 균주는 대장균 (E. coli, ATCC 25922), 파스튜렐라 헤몰리티카 (P. hemolytica, ATCC 55518), 황색 포도상구균 (S. aureus, ATCC 29213), 살모넬라 콜라라수이스 (S. cholerasuis, ATCC 7001), 살모넬라 티피뮤리움 (S. typhimurium)을 이용하였다. 상기 대상 균주를 각각 아가 배지에서 24시간 동안 계대 배양하여, 0.5 McFarland (5Ⅹ105CFU/ml)로 농도를 조절하고, 이를 ENR과 TMP이 함유된 96 웰 플레이트에 접종하여 37℃에서 24 시간 동안 배양한 후 각 균주의 성장 여부를 확인하였다. 수련 추출물 및 마보플록사신의 상호 작용은 분획별 억제 농도 (Fractional inhibitory concentration index)로 평가하였다. 일반적으로 항균제의 병합 시 FIC≤0.5인 경우 상승작용, 0.5<FIC<2 인 경우 상가작용(additive effect/indeifference), FIC≥2 이상인 경우 길항작용(antagonism)으로 판정한다. FIC를 구하는 식은 하기와 같다.Based on the above results, the following experiment was conducted by using a checkerboard method to confirm the combined effect of water extract and marbloxacin. Target strains include E. coli (ATCC 25922), P. hemolytica ( ATCC 55518), S. aureus ( ATCC 29213), S. cholerasuis 7001), was used Salmonella typhimurium (S. typhimurium). The target strains were subcultured for 24 hours in agar medium, adjusted to 0.5 McFarland ( 5 × 10 5 CFU / ml), inoculated into 96-well plates containing ENR and TMP, cultured at 37 ° C. for 24 hours And the growth of each strain was confirmed. The interaction between water extracts and marbophlogasin was evaluated by fractional inhibitory concentration index. In general, antibiotics are considered to be synergistic when FIC≤0.5, additive effect / indefinite if 0.5 <FIC <2, and antagonism if FIC≥2. The equation for obtaining FIC is as follows.
균주 종류
Strain type
(마보플폭사신기준)FIC index
(Based on moppel width god)
상호작용
Interaction
(ATCC 25922)
E. coli
(ATCC 25922)
(0.5)1.5
(0.5)
(ATCC 55518)
P. hemolytica
(ATCC 55518)
(0.25)1.25
(0.25)
(ATCC 29213)
S. aureus
(ATCC 29213)
(0.5)1.5
(0.5)
(ATCC 7001)
S. cholerasuis
(ATCC 7001)
(0.25)1.25
(0.25)
(field isolated.)
S. typhimurium
(field isolated.)
(0.5)1.5
(0.5)
표 4에 나타낸 바와 같이, 본 발명의 수련 추출물 및 마보플록사신은 각 균주에 대하여 상가 작용을 보임을 확인하였으며, 이를 통해 수련 추출물이 기존 항균제의 항균 작용을 상승시키는 항균 상승제로 이용할 수 있음을 확인하였다.
As shown in Table 4, it was confirmed that the water extract and marbophloxacin of the present invention showed an adverse effect on each strain. Thus, it was confirmed that the water extract can be used as an antimicrobial enhancer to enhance the antimicrobial activity of existing antimicrobial agents Respectively.
실험예 7. 수련 추출물의 안전성 검증Experimental Example 7. Safety Test of Water Extract
상기 실시예 1에서 수득한 수련 추출물의 안정성을 확인하기 위하여, 급성 독성 시험을 수행하였다. 시험군은 대조군(control, 0.85% NaCl), 수련 추출물 저용량군(500 mg/kg), 수련 추출물 중용량군(1,000 mg/kg) 및 수련 추출물 고용량군(2,000 mg/kg)으로 분류하였으며, 7주령의 Sprague-Dawley 계통의 특정 병원균 부재(Specific pathogen free, SPF) 랫트를 하룻밤 동안 절식시킨 후, 랫트용 존대를 이용하여 각 시료를 1회 경구 투여한 후, 14일 동안 관찰하였다. 그 결과를 표 5에 나타내었다. To confirm the stability of the water extract obtained in Example 1, an acute toxicity test was conducted. The test group was divided into control (control, 0.85% NaCl), water extract extract low dose (500 mg / kg), water extract extract medium (1,000 mg / kg) and water extract extract high dose (2,000 mg / kg) Specific pathogen free (SPF) rats of the Sprague-Dawley strain were fasted overnight, and each sample was orally administered to the rats using a single dose, followed by observation for 14 days. The results are shown in Table 5.
(mg/kg)density
(mg / kg)
표 5에 나타낸 바와 같이, 본 발명의 수련 추출물은 2,000mg/kg의 고용량을 투여했을 때에도, 암, 수 동물 모델에서 모두 사망률이 0%로 확인되었으며, 독성 증상과 관련된 임상 증상도 관찰되지 않음을 확인하였다.
As shown in Table 5, when the water extract of the present invention was administered at a dose of 2,000 mg / kg, the mortality rate was 0% in both cancer and animal models, and no clinical symptoms related to toxic symptoms were observed Respectively.
실험예 8. 수련 추출물의 GC-MS 분석Experimental example 8. GC-MS analysis of water extract
상기 실시예 1에서 수득한 수련 추출물에 포함된 주요 성분을 확인하기 위하여, 경북대학교 공동실험실습관에서 GC/MS(Gas Chromatography Coupled Mass Spectroscopy) 분석을 수행하였다. 그 결과를 표 6에 나타내었다. GC / MS (Gas Chromatography Coupled Mass Spectroscopy) analysis was performed at Kyungpook National University joint lab habit to identify the major components contained in the water extract obtained in Example 1. [ The results are shown in Table 6.
실험예 9. 수련 추출물을 포함하는 사료 첨가제의 살모넬라 억제 효과 검증Experimental Example 9. Inhibition of Salmonella Inhibition by Feed Additives Containing Water Extracts
수련 추출물을 포함하는 사료 첨가제의 살모넬라 억제 효과를 확인하기 위하여, 경북 군위군 군위읍 칠곡면 둥지양돈장에서 이유자돈을 이용하여 하기와 같은 실험을 수행하였다. 음성대조군(n=10)은 3%의 수련 추출물만 사료에 첨가하였다. 실험군에는 모두 살모넬라를 접종하였으며, 수련 추출물 무첨가군(n=10), 0.1% 수련 추출물 첨가군(n=10), 1% 수련 추출물 첨가군(n=10) 및 3% 수련 추출물 첨가군(n=10)으로 나누었다. 살모넬라 접종 후 1주, 2주, 3주에 분변시료를 채취하여 살모넬라의 증식 여부를 조사하였다. 그 결과를 도 7에 나타내었다. In order to confirm the inhibitory effect of feed additive including water extracts on Salmonella, the following experiment was carried out using a weedy pig in a nursery pig farm in Chilgok - myeon, In the negative control (n = 10), only 3% of the water extracts were added to the feed. All the experimental groups were inoculated with salmonella and the group with no water extract (n = 10), group with 0.1% water extract (n = 10), group with 1% water extract (n = 10) = 10). The fecal samples were collected at 1, 2, and 3 weeks after the inoculation of Salmonella to investigate the growth of Salmonella. The results are shown in Fig.
도 7에 나타낸 바와 같이, 3% 수련 추출물 첨가군은 2주째부터 살모넬라의 증식이 억제되었으며, 0.1% 수련 추출물 첨가군은 3주째부터 살모넬라의 증식이 억제되었다. As shown in Fig. 7, the growth of Salmonella was inhibited from the 2nd week of the group supplemented with 3% water extract, and the growth of Salmonella was inhibited from the 3rd week after the addition of the 0.1% water extract.
Claims (8)
Water roots powder: Ether was shaken at a weight ratio of 1: 5 to 15, and the mixture was allowed to stand to remove the ether layer as an upper layer. The resulting powder was dissolved in ethanol; 40 to 60% (v / v) aqueous ethanol solution; C. violaceum containing as an active ingredient a water extract obtained by extracting each of the extracts with water and water and then mixing the extracts in a weight ratio of 1: 2: 1 to 2: 1: 2, (Pseudomonas aeruginosa), E. coli, P. hemolytica, S. aureus, S. cholerasuis, and Salmonella typhi And S. typhimurium. ≪ RTI ID = 0.0 > 11. < / RTI >
The antimicrobial composition according to claim 1, wherein the mixing weight ratio is 1: 1: 1.
상기 수련 추출물은 수련 뿌리 분말:에테르를 1:5~15의 중량 비율로 진탕 후 정치하여 상층액인 에테르 층을 제거하고 얻은 분말을, 에탄올; 40~60%(v/v)의 에탄올 수용액; 및 열수;로 각각 추출한 후, 각 추출물을 1~2:1~2:1~2의 중량 비율로 혼합한 것을 특징으로 하는, 항균 활성을 갖는 사료 첨가용 조성물.
A feed additive composition having an antibacterial activity comprising a water extract as an active ingredient,
The water lily extract was prepared by shaking water lily root powder: ether in a weight ratio of 1: 5 to 15, and removing the ether layer as an upper layer liquid. The resulting powder was dissolved in ethanol; 40 to 60% (v / v) aqueous ethanol solution; Wherein the extracts are mixed with each other at a weight ratio of 1: 2: 1 to 2: 1: 2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20120113692 | 2012-10-12 | ||
KR1020120113692 | 2012-10-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140047563A KR20140047563A (en) | 2014-04-22 |
KR101625891B1 true KR101625891B1 (en) | 2016-05-31 |
Family
ID=50654093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020130122095A KR101625891B1 (en) | 2012-10-12 | 2013-10-14 | Composition for inhibiting quorum sensing or anti-bacterial composition comprising Nymphaea tetragona georgi extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101625891B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200027381A (en) | 2018-09-04 | 2020-03-12 | 경북대학교 산학협력단 | The composition and preparation method of quorum quenching media of core-shell structure for anti-biofouling strategy |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110742198A (en) * | 2019-11-21 | 2020-02-04 | 中国科学院烟台海岸带研究所 | Antibiotic reduction preparation for breeding industry and preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100876440B1 (en) * | 2006-04-27 | 2008-12-29 | 사단법인 우리문화가꾸기회 | Antistress or antidepressant composition comprising water lily extract |
-
2013
- 2013-10-14 KR KR1020130122095A patent/KR101625891B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100876440B1 (en) * | 2006-04-27 | 2008-12-29 | 사단법인 우리문화가꾸기회 | Antistress or antidepressant composition comprising water lily extract |
Non-Patent Citations (3)
Title |
---|
「올 여름을 강타할 핫한 헤어 & 뷰티 신제품 소식」, 조선일보 기사(2009.07.28.)* |
Biosci. Biotech. Biochem., Vol. 57(9), pp. 1570-1571(1993년)* |
Journal of Bacteriology, Vol. 187(5), pp. 1799-1814(2005년)* |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200027381A (en) | 2018-09-04 | 2020-03-12 | 경북대학교 산학협력단 | The composition and preparation method of quorum quenching media of core-shell structure for anti-biofouling strategy |
Also Published As
Publication number | Publication date |
---|---|
KR20140047563A (en) | 2014-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alam et al. | Antibacterial activity of different organic extracts of Achyranthes aspera and Cassia alata | |
Owolabi et al. | Antifungal and antibacterial activities of the ethanolic and aqueous extract of Kigelia africana (Bignoniaceae) stem bark | |
Akinpelu et al. | Evaluation of antibacterial and antifungal properties of Alchornea laxiflora (Benth.) Pax. & Hoffman | |
Bankole et al. | Synergistic antimicrobial activities of phytoestrogens in crude extracts of two sesame species against some common pathogenic microorganisms | |
Bensizerara et al. | Antimicrobial activity of xerophytic plant (Cotula cinerea Delile) extracts against some pathogenic bacteria and fungi | |
Sabir et al. | Antibacterial activity of Elaeagnus umbellata (Thunb.) a medicinal plant from Pakistan | |
Maikai et al. | Antimicrobial properties of stem bark extracts of Ximenia americana | |
Sreenivasa et al. | Phytochemical analysis, antibacterial and antioxidant activity of leaf extract of Datura stramonium | |
Nwadinigwe | Antimicrobial activities of methanol and aqueous extracts of the stem of Bryophyllum pinnatum Kurz (Crassulaceae) | |
Nwachukwu et al. | Antimicrobial activities of leaf of Vitex doniana and Cajanus cajan on some bacteria | |
Adeyemo et al. | Anti-Biofilm, antibacterial, and anti-quorum sensing activities of selected South African plants traditionally used to treat diarrhoea | |
KR101625891B1 (en) | Composition for inhibiting quorum sensing or anti-bacterial composition comprising Nymphaea tetragona georgi extract | |
Abdelkader et al. | Antimicrobial activity of Rhaponticum acaule and Scorzonera undulata growing wild in Tunisia | |
KR101817186B1 (en) | Composition for inhibiting quorum sensing comprising Citrus junos extact as effective component | |
Gbadamosi et al. | An appraisal of the potency of roots of Anogeissus leiocarpus (DC.) Guill. & Perr. and Terminalia glaucescens Benth. in the management of E. coli related infections | |
Auwal et al. | Antibacterial properties of crude pod extract of Acacia nilotica (Fabaceae). | |
KR100729182B1 (en) | Antimicrobial composition containing the essential oil of Rosmarinus officinalis L. and the conventional antibiotics | |
Tyagi et al. | Antimicrobial and antioxidant activity of Pistia stratiotes (L.) | |
Lee et al. | Inhibition of growth and urease of Helicobacter pylori by Korean edible seaweed extracts | |
CN111840340A (en) | Application of pomegranate bark tannin in preparation of medicine for inhibiting bacterial quorum sensing system | |
Antwi-Boasiako et al. | Anti-Microbial and Phyto-Chemical Properties of Crude Extracts of Garcinia kola Heckel Stems Used for Oral Health | |
Eboh et al. | Metabolites of Colletrotricum species, an endophytic fungus isolated from Vernonia amygdalina Del possess antimicrobial and antioxidant activities | |
Ogundare et al. | Antibacterial activities of the plant extract of Alternanthera repens | |
Akabueze et al. | Antimicrobial and phytochemical attributes of Dennettia tripetala F. baker root and bark extracts | |
Kenneth et al. | Phytochemical and antimicrobial properties of crude n-hexane and methanol extracts of Cola acuminata nuts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20190527 Year of fee payment: 4 |